ANAB
USDAnaptysBio Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$35.970
High
$36.500
Low
$34.595
Volume
0.76M
Company Fundamentals
Market Cap
971.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.52M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update
Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on track for Nov./Dec.
Anaptys Announces Participation in November Investor Conferences
SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president
Stifel Maintains Buy on AnaptysBio, Raises Price Target to $80
Stifel analyst Alex Thompson maintains AnaptysBio with a Buy and raises the price target from $55 to $80.
Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
New data reinforce rosnilimab's efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced therapy, including
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.